EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 54 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $4,679,000 | -34.4% | 475,000 | -7.1% | 0.71% | -15.2% |
| Q4 2017 | $7,135,000 | +24.7% | 511,469 | -1.7% | 0.84% | +2.4% |
| Q3 2017 | $5,723,000 | +88.0% | 520,269 | +35.0% | 0.82% | +58.0% |
| Q2 2017 | $3,044,000 | -31.0% | 385,301 | 0.0% | 0.52% | -40.1% |
| Q1 2017 | $4,412,000 | -1.7% | 385,301 | 0.0% | 0.86% | -24.0% |
| Q4 2016 | $4,489,000 | -10.3% | 385,301 | +3.1% | 1.14% | +39.6% |
| Q3 2016 | $5,002,000 | +67.5% | 373,568 | +147.9% | 0.81% | +4.9% |
| Q2 2016 | $2,987,000 | +20.7% | 150,716 | +2.2% | 0.78% | +44.8% |
| Q1 2016 | $2,474,000 | – | 147,514 | – | 0.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 1,787,091 | $14,118,000 | 3.56% |
| INTERWEST VENTURE MANAGEMENT CO | 1,599,592 | $12,637,000 | 2.99% |
| SPHERA FUNDS MANAGEMENT LTD. | 385,301 | $3,044,000 | 0.52% |
| Boxer Capital, LLC | 138,331 | $1,093,000 | 0.26% |
| DAFNA Capital Management LLC | 35,977 | $284,000 | 0.20% |
| SABBY MANAGEMENT, LLC | 223,100 | $1,762,000 | 0.12% |
| Hikari Power Ltd | 60,992 | $482,000 | 0.06% |
| Perceptive Advisors | 157,679 | $1,245,000 | 0.06% |
| Lombard Odier Asset Management (USA) Corp | 90,000 | $711,000 | 0.06% |
| TFS CAPITAL LLC | 12,128 | $96,000 | 0.04% |